Institute for Aging & Alzheimer's Disease Research

The impact of Alzheimer’s disease on individuals, families and the healthcare system makes it one of America’s greatest medical, social and economic challenges.  Our scientists in the Institute for Aging and Alzheimer’s Disease Research are doing something about it.

Our research team is focused on early detection of Alzheimer’s, estrogen’s role in Alzheimer’s and Parkinson’s, stroke therapy and identification of oxidation processes to measure brain aging.

We’re also taking our research from the bench to the bedside.  Currently, we have several drugs in clinical trials for the treatment of Alzheimer’s disease, Parkinson’s disease and stroke. And, we’re partners with private-sector biotechnology and pharmaceutical companies in the development of treatments for neurological disorders.

In addition, we work closely with the local Alzheimer’s Association, and support educational and health promotion programs that encourage healthy brain aging in our community.

Application for the Neurobiology of Aging Predoctoral Fellowship